THEMIS MEDICARE
Quarterly Results Analysis [Dec2024]
THEMIS MEDICARE Quarterly Results
Consolidated | Dec2024 UnAudited |
Sep2024 UnAudited |
Jun2024 UnAudited |
Mar2024 Audited |
Dec2023 Audited |
Sep2023 UnAudited |
Jun2023 UnAudited |
Mar2023 UnAudited |
---|---|---|---|---|---|---|---|---|
Revenues | ₹94 Cr | ₹117 Cr | ₹123 Cr | ₹98 Cr | ₹83 Cr | ₹105 Cr | ₹97 Cr | ₹80 Cr |
Expenses | ₹85 Cr | ₹100 Cr | ₹94 Cr | ₹89 Cr | ₹74 Cr | ₹92 Cr | ₹75 Cr | ₹70 Cr |
Operating Income | ₹9 Cr | ₹17 Cr | ₹29 Cr | ₹9 Cr | ₹8 Cr | ₹12 Cr | ₹22 Cr | ₹10 Cr |
Other Income | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹2 Cr | ₹1 Cr | ₹3 Cr |
Interest | ₹3 Cr | ₹2 Cr | ₹2 Cr | ₹2 Cr | ₹3 Cr | ₹2 Cr | ₹2 Cr | ₹3 Cr |
Depreciation | ₹3 Cr | ₹2 Cr | ₹2 Cr | ₹3 Cr | ₹3 Cr | ₹3 Cr | ₹3 Cr | ₹3 Cr |
Profit Before Tax | ₹4 Cr | ₹13 Cr | ₹25 Cr | ₹5 Cr | ₹3 Cr | ₹10 Cr | ₹17 Cr | ₹8 Cr |
Profit After Tax | ₹3 Cr | ₹10 Cr | ₹19 Cr | ₹3 Cr | ₹2 Cr | ₹7 Cr | ₹13 Cr | ₹6 Cr |
EPS | ₹0.06 | ₹1.55 | ₹2.68 | ₹0.72 | ₹0.80 | ₹1.23 | ₹1.98 | ₹0.91 |
Industry Peers & Returns | 1W | 1M | 1Y |
THEMIS MEDICARE | -3.7% | -30.4% | -24.9% |
SUN PHARMACEUTICAL INDUSTRIES | -4.1% | -9.8% | 8.2% |
DIVIS LABORATORIES | -2.9% | -0.3% | 63.8% |
CIPLA | 0.1% | 4.4% | 2.2% |
TORRENT PHARMACEUTICALS | -1.3% | -6.5% | 19% |
DR REDDYS LABORATORIES | -4% | -5.9% | -7.8% |
MANKIND PHARMA | -0.8% | -7.2% | 7.2% |
ZYDUS LIFESCIENCES | -4.2% | -7.5% | 0.8% |
LUPIN | -5.9% | -10.7% | 23.6% |
THEMIS MEDICARE Quarterly Revenues
Revenues | |
---|---|
Q-o-Q | -19.83 % |
Y-o-Y | 13.69 % |
Quarters | Revenues | % Change | |
---|---|---|---|
Dec2024 | ₹94 Cr | -19.83 | |
Sep2024 | ₹117 Cr | -4.87 | |
Jun2024 | ₹123 Cr | 25.74 | |
Mar2024 | ₹98 Cr | 18.55 | |
Dec2023 | ₹83 Cr | -21.25 | |
Sep2023 | ₹105 Cr | 8.42 | |
Jun2023 | ₹97 Cr | 20.65 | |
Mar2023 | ₹80 Cr | - |
THEMIS MEDICARE Quarterly Operating Profit
Operating Profit | |
---|---|
Q-o-Q | -50.21 % |
Y-o-Y | 5.77 % |
Quarters | Operating Profit | % Change | |
---|---|---|---|
Dec2024 | ₹9 Cr | -50.21 | |
Sep2024 | ₹17 Cr | -41.29 | |
Jun2024 | ₹29 Cr | 213.86 | |
Mar2024 | ₹9 Cr | 15.29 | |
Dec2023 | ₹8 Cr | -35.00 | |
Sep2023 | ₹12 Cr | -42.95 | |
Jun2023 | ₹22 Cr | 107.43 | |
Mar2023 | ₹10 Cr | - |
Operating Margins | |
---|---|
Q-o-Q | -37.91 % |
Y-o-Y | -6.96 % |
Quarters | Operating Margin% | % Change | |
---|---|---|---|
Dec2024 | 9.09% | -37.91 | |
Sep2024 | 14.64% | -38.28 | |
Jun2024 | 23.72% | 149.68 | |
Mar2024 | 9.5% | -2.76 | |
Dec2023 | 9.77% | -17.48 | |
Sep2023 | 11.84% | -47.38 | |
Jun2023 | 22.5% | 72.02 | |
Mar2023 | 13.08% | - |
THEMIS MEDICARE Quarterly Profit After Tax
Profit After Tax(PAT) | |
---|---|
Q-o-Q | -68.78 % |
Y-o-Y | 54.36 % |
Quarters | Profit After Tax | % Change | |
---|---|---|---|
Dec2024 | ₹3 Cr | -68.78 | |
Sep2024 | ₹10 Cr | -47.24 | |
Jun2024 | ₹19 Cr | 508.98 | |
Mar2024 | ₹3 Cr | 53.91 | |
Dec2023 | ₹2 Cr | -71.87 | |
Sep2023 | ₹7 Cr | -43.47 | |
Jun2023 | ₹13 Cr | 107.92 | |
Mar2023 | ₹6 Cr | - |
PAT Margins | |
---|---|
Q-o-Q | -61.14 % |
Y-o-Y | 35.54 % |
Quarters | PAT Margin(%) | % Change | |
---|---|---|---|
Dec2024 | 3.28 % | -61.14 | |
Sep2024 | 8.44 % | -44.51 | |
Jun2024 | 15.21 % | 384.39 | |
Mar2024 | 3.14 % | 29.75 | |
Dec2023 | 2.42 % | -64.25 | |
Sep2023 | 6.77 % | -47.88 | |
Jun2023 | 12.99 % | 72.28 | |
Mar2023 | 7.54 % | - |
THEMIS MEDICARE Quarterly Earnings Per Share (EPS)
EPS | |
---|---|
Q-o-Q | -96.13 % |
Y-o-Y | -92.50 % |
Quarters | EPS | % Change | |
---|---|---|---|
Dec2024 | ₹0.06 | -96.13 | |
Sep2024 | ₹1.55 | -42.16 | |
Jun2024 | ₹2.68 | 272.22 | |
Mar2024 | ₹0.72 | -10.00 | |
Dec2023 | ₹0.8 | -34.96 | |
Sep2023 | ₹1.23 | -37.88 | |
Jun2023 | ₹1.98 | 117.58 | |
Mar2023 | ₹0.91 | - |
You may also like the below Video Courses
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs CIPLA LTD
TORRENT PHARMACEUTICALS LTD vs DR REDDYS LABORATORIES LTD vs MANKIND PHARMA LTD